Status:
TERMINATED
Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection
Lead Sponsor:
Bayside Health
Conditions:
Hepatitis C
HIV Infections
Eligibility:
All Genders
18-80 years
Brief Summary
The purpose of this study is to examine the effect of GB virus C (GBV-C) on the natural history of chronic hepatitis C virus (HCV) infection in subjects co-infected with HIV and HCV. The other aspect ...
Detailed Description
Background and Research Plan: GBV-C and hepatitis G virus (HGV) are both RNA viruses from the Flaviviridae family. Molecular characterization of these viruses has shown them to be virtually identical...
Eligibility Criteria
Inclusion
- Sera available and appropriate for testing, including serial sera over a period of time (retrospective analysis)
- HIV serology positive.
- Unequivocal HCV antibody positive or HCV RNA positive.
Exclusion
- Those without sera available.
- Those unwilling to give informed consent.
- Persons with hepatitis B virus infection, as defined by the presence of hepatitis B surface antigen and/or hepatitis B virus DNA positive.
Key Trial Info
Start Date :
February 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
158 Patients enrolled
Trial Details
Trial ID
NCT00164060
Start Date
February 1 2004
End Date
May 1 2007
Last Update
December 5 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alfred Hospital
Melbourne, Victoria, Australia, 3181